News and Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Center for Diabetes and Metabolism. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards, and honors.
03.09.2026Northwestern Medicine scientists have discovered how disruptions in circadian rhythm impair metabolic function in fat cells, providing new insights into the molecular mechanisms that cause obesity and metabolic disease, according to a recent study published in Nature Metabolism.
12.05.2025While menopausal hormone therapy increased cardiovascular disease risk in postmenopausal women older than 70 years with vasomotor symptoms, hormone therapy did not significantly affect cardiovascular disease risk in younger postmenopausal women, according to a recent study published in JAMA Internal Medicine.
11.17.2025Twelve Feinberg faculty members were named to the 2025 “Highly Cited Researchers” list, published by Clarivate Analytics. The annual list identifies investigators who have demonstrated significant influence in their field through the publication of highly cited publications over the preceding eleven years.
10.23.2025A recent Northwestern Medicine study has identified novel neural circuits modulated by the diabetes and obesity-management drugs semaglutide and tirzepatide that help suppress appetite, according to findings published in The Journal of Clinical Investigation.
10.20.2025Joseph Bass, MD, PhD, the Charles F. Kettering Professor of Medicine, has been elected to the National Academy of Medicine for his foundational work in expanding the field of circadian mechanisms in metabolic health and disease.
08.15.2025A novel drug may significantly improve outcomes for a subset of patients with high blood pressure, according to findings published in The New England Journal of Medicine.